Strengthening Value Assessment and Health Economics and Outcomes Research Proposals Through Patient Engagement: Guidelines for Researchers [0.03%]
通过患者参与加强价值评估和卫生经济学及结果研究提案：研究人员指南
Elizabeth F Franklin,Benjamin M Craig,Justin Hopkin et al.
Elizabeth F Franklin et al.
Patient engagement in value assessment and health economics and outcomes research (HEOR) must be meaningful and authentic, not simply patient participation as study subjects. This article provides researchers with guidelines for incorporati...
Parent and Adolescent Preferences for Online Youth Mental Health Support Programs: A Discrete Choice Experiment [0.03%]
家长和青少年对在线青年心理健康支持项目偏好的离散选择实验
Sanjeewa Kularatna,Michelle J Allen,Sonja March et al.
Sanjeewa Kularatna et al.
Background: Digital mental health programs can expand access to psychological support for children and adolescents, especially where stigma, cost, and workforce shortages limit traditional care. Understanding which featur...
A Review of Methods Used to Assess Treatment Tolerability in Clinical Trials [0.03%]
临床试验中评估治疗耐受性的方法述评
Ari Gnanasakthy,Margaret Mordin,Jane Chang et al.
Ari Gnanasakthy et al.
Clinical tolerability refers to the degree to which patients can endure side effects without discontinuing treatment. Despite its frequent inclusion alongside efficacy and safety, tolerability in clinical trial publications is typically rep...
Extending the Interpretation of Patient-Reported Outcome Scores through Patient-Preference Information [0.03%]
通过患者偏好信息扩展对患者报告结果评分的解释
Juan Marcos Gonzalez Sepulveda,Theresa Coles
Juan Marcos Gonzalez Sepulveda
Editorial
The patient. 2026 Jul 25. DOI:10.1007/s40271-026-00826-1 2026
Patient Preferences for Inflammatory Bowel Disease Treatment: Results from a Global Survey Conducted in Partnership with the European Federation of Crohn's & Ulcerative Colitis Associations [0.03%]
全球炎症性肠病治疗偏好调查结果与欧洲克罗恩病及结肠炎协会联合会合作开展
Elise Schoefs,Séverine Vermeire,Maria Stella De Rocchis et al.
Elise Schoefs et al.
Background: As therapeutic options for inflammatory bowel disease (IBD) expand, understanding patient preferences-and how these vary across subgroups-is critical for patient-centered drug development and evaluation. This ...
Preferences for Parkinson's Disease Treatments: A Scoping Literature Review [0.03%]
帕金森病治疗的偏好：系统综述文献式回顾
Pablo Arija,Marco Boeri,Connie H Yan et al.
Pablo Arija et al.
Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms that significantly impact quality of life. As the disease advances, treatment options expand ...
Women's Treatment Preferences for Moderate to Severe Vasomotor Symptoms Associated with Menopause: Insights from the WARMER Study [0.03%]
绝经相关中重度血管舒缩症状女性治疗偏好研究——WARMER研究启示
Sebastian Heidenreich,Tommaso Simoncini,Katelyn Cutts et al.
Sebastian Heidenreich et al.
Background and objective: Vasomotor symptoms (VMS) affect up to 80% of women over the course of their menopause and can impair functioning as well as quality of life. Hormone therapy (HT) is the standard of care, but conc...
The Choice of Task Format can Affect the Quality of Published Best-Worst Scaling Studies [0.03%]
任务格式的选择可能会影响最佳-最差_scaling研究的质量
Nicola B Campoamor,Anne L R Schuster,Norah L Crossnohere et al.
Nicola B Campoamor et al.
Best-worst scaling (BWS) is a theory-driven method to measure priorities with growing applications in health and other literatures. Priorities in BWS are elicited through a series of choice tasks. While several study design factors have bee...
Co-Creation of the EpiCom Clinical Trial: Bringing the Tuberous Sclerosis Complex Patient Community, Healthcare Professionals, and the Pharmaceutical Industry Together [0.03%]
EpiCom临床试验的共创：连接结节性硬化症患者社群、医疗专业人士和医药行业各方的力量
Lisa Moore-Ramdin,Agnies van Eeghen,Joanne Stevens et al.
Lisa Moore-Ramdin et al.
Background: Tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND) affect most patients with TSC and encompass a range of psychiatric, intellectual, neuropsychological, and behavioral manifestations...
Should Qualitative Researchers in Health and Medicine be Concerned About Replication? [0.03%]
健康与医学领域的定性研究人员需要关心重复验证吗？
Patti Shih,Stacy M Carter
Patti Shih
Editorial
The patient. 2026 Jul 1. DOI:10.1007/s40271-026-00832-3 2026